VIPR2微重复剂量敏感不耐受导致精神分裂症样表型的新型BAC转基因小鼠模型
该研究基于GWAS发现的7q36.3染色体VIPR2微重复与精神分裂症风险的关联,构建了条件性VIPR2细菌人工染色体转基因小鼠模型。模型重现了人类CNV携带者的基因表达和信号缺陷,表现出纹状体多巴胺功能障碍及认知、感觉运动门控和社交行为缺陷,且通过Drd1a-Cre去除VIPR2转基因可逆转上述异常。结果表明VIPR2剂量敏感不耐受是导致精神分裂症样表型的致病因素。
要点
- VIPR2微重复小鼠重现人类CNV携带者的基因表达与信号缺陷。
- 小鼠表现出纹状体多巴胺功能障碍及认知、感觉运动门控和社交行为缺陷。
- 在Drd1a-Cre小鼠中去除VIPR2转基因可逆转多巴胺D2受体异常和行为缺陷。
核心结论
- VIPR2剂量敏感不耐受是导致小鼠精神分裂症样多巴胺、认知和社交行为缺陷的致病因素。
研究设计与样本
- 研究开发了一系列条件性VIPR2细菌人工染色体转基因小鼠模型来模拟VIPR2拷贝数变异。
主要发现
- VIPR2微重复小鼠出现显著的背侧纹状体多巴胺功能障碍、认知、感觉运动门控和社交行为缺陷。
- 上述行为缺陷之前伴有纹状体cAMP/PKA信号增加和早期出生后纹状体发育 disrupted。
- 通过Drd1a-Cre去除VIPR2转基因表达可挽救多巴胺D2受体异常和多种行为缺陷。
临床怎么用
- 该病因相关的小鼠模型为药物发现提供了有用的临床前平台,对治疗开发具有重要意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent genome-wide association studies (GWAS) have identified copy number variations (CNVs) at chromosomal locus 7q36.3 that significantly contribute to the risk of schizophrenia, with all of the microduplications occurring within a single gene: vasoactive intestinal peptide receptor 2 (VIPR2). To confirm disease causality and translate such a genetic vulnerability into mechanistic and pathophysiological insights, we have developed a series of conditional VIPR2 bacterial artificial chromosome (BAC) transgenic mouse models of VIPR2 CNV. VIPR2 CNV mouse model recapitulates gene expression and signaling deficits seen in human CNV carriers. VIPR2 microduplication in mice elicits prominent dorsal striatal dopamine dysfunction, cognitive, sensorimotor gating, and social behavioral deficits preceded by an increase of striatal cAMP/PKA signaling and the disrupted early postnatal striatal development. Genetic removal of VIPR2 transgene expression via crossing with Drd1a-Cre BAC transgenic mice rescued the dopamine D2 receptor abnormality and multiple behavioral deficits, implicating a pathogenic role of VIPR2 overexpression in dopaminoceptive neurons. Thus, our results provide further evidence to support the GWAS studies that the dosage sensitivity intolerance of VIPR2 is disease causative to manifest schizophrenia-like dopamine, cognitive, and social behavioral deficits in mice. The conditional BAC transgenesis offers a novel strategy to model CNVs with a gain-of -copies and facilitate the genetic dissection of when/where/how the genetic vulnerabilities affect development, structure, and function of neural circuits. Our findings have important implications for therapeutic development, and the etiology-relevant mouse model provides a useful preclinical platform for drug discovery.
引用
- Tian X, Richard A, El-Saadi MW, et al. Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model. Mol Psychiatry. 2019. PMID: 31444475. doi:10.1038/s41380-019-0492-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。